Liberum appointed Nomad and Sole Corporate Broker to Futura Medical

Liberum is pleased to announce its appointment as Nomad and Sole Broker to Futura Medical plc.

Futura Logo

Futura Medical is a pharmaceutical company with a pipeline of transdermal delivery products in late stage development. The company’s lead product is MED2005, a topical treatment for erectile dysfunction currently in Phase 3 clinical trial. The company was founded in 1997 and was admitted to trading on AIM in 2003.

Liberum has been appointed as Nomad and Sole Broker with immediate effect.

Liberum Team

Board – David Parsons

Investment Banking – Bidhi Bhoma, Euan Brown, Kane Collings

Research – Graham Doyle, Alistair Campbell

Sales – Lisa Tugwell, Oliver Baxendale, Julian Collett

Corporate and Investor Relations – Natalie Clarke



New York


Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY

New York

20th Floor 575 Fifth Avenue New York NY 10017